Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab

Journal of Clinical Rheumatology

Volumn 16, Issue 2, 2010, Pages 79-80

  Wechalekar, Mihir D ^a   Rischmueller, Maureen ^a   Whittle, Samuel ^a   Burnet, Simon ^a   Hill, Catherine L ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Reactive arthritis; TNF antagonists

Indexed keywords

CORTICOSTEROID; DICLOFENAC; DOXYCYCLINE; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; OXYCODONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; CHLAMYDIA TRACHOMATIS; CHRONIC ARTHRITIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; LABORATORY TEST; NEISSERIA GONORRHOEAE; PAIN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REMISSION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, REACTIVE; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS;

EID: 77949484278     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181d06f70     Document Type: Article

References (15)

1. Kvien TK, Gaston JS, Bardin T, et al.. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis. 2004;63:1113-1119.
2. Bleehen SS, Everall JD, Tighte JR. Amyloidosis complicating Reiter's syndrome. Br J Vener Dis. 1966;42:88-92.
3. Caughey DE, Waken CJ. A fatal case of Reiter's disease complicated by amyloidosis. Arthritis Rheum. 1973;16:695-700.
4. Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol. 2005;34:251-259.
5. Clegg DO, Reda DJ, Weisman MH, et al.. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative study. Arthritis Rheum. 1996;39:2021-2027.
6. Flagg SD, Meador R, Hisa E, et al.. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trail. Arthritis Rheum. 2005;53:613-617.
7. Kaipiainen-Seppanen, Niinisalo H, Korpilahde T, et al.. Treatment of reactive arthritis with infliximab. Scand J Rheumatol. 2003;32:122-124.
8. Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome. J Rheumatol. 2003;30:407-411.
9. Gill H, Majithia V. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion. Clin Rheumatol. 2008;27:121-123.
10. Braun J, Kingsley G, van der Heijde D, et al.. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. Rheumatology. 2000;27:2185-2192.
11. Fendler C, Laitko S, Sorensen H, et al.. Frequency of triggering bacterial in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2001;60: 337.
12. Leirisalo M, Skylv G, Kousa M, et al.. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982;25:249-259.
13. Tuokko J, Koskinen S, Westman P, et al.. Tumour necrosis factor microsatellites in reactive arthritis. Br J Rheumatol. 1998;37:1203-1206.
14. Meador R, Hsia E, Kitumnuaypong T, et al.. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002; 20(suppl 28):S130-S134.
15. Butrimiene I, Jarmalaite S, Ranceva J, et al.. Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology. 2004;43: 1300-1303.